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Medical treatment of asthma and knowledge
about asthma’s biologic mechanisms have
improved in recent years. Yet asthma preva-
lence, hospitalization rates, and mortality
rates continue to rise internationally in both
adults and children (1–5). According to the
Centers for Disease Control and Prevention,
the number of individuals with self-reported
asthma increased by 75% in the United
States from 1980 to 1994 (6). The increase
was seen in all races, both sexes, and all age
groups, but nonwhite children have been
particularly affected. The prevalence of pedi-
atric asthma increased by 160% during the
same time period in children under 4 years of
age and by 74% in children over age 4 (7).
Not only is the prevalence of asthma rising in
industrialized countries, but also the severity
among those afﬂicted has increased. A recent
cross-sectional study found that the odds of
an adverse outcome (i.e., intubation, car-
diopulmonary arrest, or death) among chil-
dren hospitalized for asthma in California
doubled between 1986 and 1993 (8).
Asthma is more prevalent in the urban-
ized areas of industrialized countries (9).
Numerous studies have demonstrated that
speciﬁc components of air pollution may be
associated with exacerbations of asthma
(10–14). Although the levels of coarse partic-
ulate matter in the atmosphere have
decreased over recent decades, the levels of
ﬁne particulate matter smaller than 2.5 µm in
size (PM2.5), such as diesel exhaust particles
(DEPs), remain an ongoing problem (15).
Ambient air pollution has been associated
with hospitalizations and deaths due to
exacerbations of cardiovascular and respira-
tory diseases (15). Particulate air pollution
has also been linked more specifically to
asthma (16,17).
Some of the evidence linking particulate
air pollution and asthma is indirect. For
instance, several studies found that children
raised in more polluted regions of a country
are more likely to develop respiratory dis-
eases and allergies compared with children
raised in “cleaner” regions (18,19). Within
communities, children living on busy
streets have a higher likelihood of develop-
ing chronic respiratory symptoms than
those living on streets with lower trafﬁc vol-
ume (10,20). When exposed to similar lev-
els of Japanese cedar pollen (a standard
allergen), people who live in highly traf-
ficked areas have enhanced allergic reac-
tions compared with people who live in
rural areas. This suggests the possibility of a
synergistic effect between air pollution and
aeroallergens (21).
Diesel exhaust and DEPs have previously
been associated with asthma (22–24).
Current evidence supports the hypothesis
that components of diesel exhaust worsen
respiratory symptoms in individuals with
preexisting asthma or allergies, and offers
some support for the hypothesis that diesel
exhaust and DEPs may play a role in causing
asthma (25–28). This paper critically ana-
lyzes the research relevant to the question of
whether diesel exhaust exposure is associated
with asthma. We also review molecular
mechanisms by which particulate matter in
diesel exhaust may facilitate and promote
asthmatic symptoms.
Molecular Basis for the
Inﬂammatory Events 
in Asthma
Asthma is a chronic respiratory disease mani-
fested by bronchial hyperresponsiveness,
reversible bronchial constriction, airway
inflammation, and respiratory symptoms
such as wheezing, dyspnea, coughing, and
chest tightness (29,30). A complex immuno-
logic cascade, including recruitment of
inﬂammatory cells from the bloodstream to
the bronchial mucosa, is characteristic of
asthma (31).
During asthma attacks, both inﬂammatory
and structural cells of the respiratory tract are
activated. Activated cells include T cells, mast
cells, eosinophils, macrophages, epithelial
cells, ﬁbroblasts, and bronchial smooth mus-
cle cells. By releasing proinflammatory and
cytotoxic mediators and cytokines, these cells
are all involved in a cascade that leads to the
acute and chronic symptoms of asthma (30).
Figure 1 summarizes the immunologic events
involved in asthma.
T lymphocytes appear to play a particu-
larly important role in airway inﬂammation.
T cells have been demonstrated in the air-
ways of patients with fatal asthma (32) and
appear to be vital for regulating the immune
pathways that control allergic immune
responses (31). In general, T cells can be
classified into two major subsets consisting
of CD4+ or CD8+ cells. CD4+ T cells
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T cells, including T helper 1 (TH1) and
T helper 2 (TH2) (33). A shift in the pre-
dominant T-cell population from the TH1
type to the TH2 type has been associated
with asthma (34).
T helper cells release specific cytokines
that mediate inflammation. TH1-type cells
produce interferon γ, interleukin-2 (IL-2),
and tumor necrosis factor β (TNF-β),
whereas TH2-type cells produce IL-4, IL-5,
IL-6, IL-10, and IL-13. In addition, both
TH1 and TH2 produce some common
cytokines (i.e., IL-1, IL-3, IL-8, TNF-α,
and granulocyte-macrophage colony–stimu-
lating factor (GM–CSF) (31). The TH2 and
common cytokines are the signaling mole-
cules that have been most strongly linked to
asthmatic responses.
Immunoglobulins, cytokines, and
chemokines appear to play important roles in
the inﬂammatory foundation of asthma. For
example, IL-5 promotes the development
and survival of eosinophils, the cells that help
drive the chronic asthmatic response. IL-8 is
a potent chemoattractant for neutrophils and
primes eosinophil responses. IL-10 builds
and prolongs the immune response by stimu-
lating production of more TH2 cells. IL-4
and IL-13 act on B cells to stimulate produc-
tion of antigen-specific immunoglobulin E
(IgE), and GM–CSF is an important growth
and survival factor for neutrophils,
eosinophils, and macrophages. The relation-
ship between these molecules and the even-
tual clinical symptomatology of asthma is
illustrated in Figure 1.
Theories on the Etiology 
of Asthma
Genetic and environmental factors interact
to cause asthma (1). There is substantial epi-
demiologic evidence, supported by clinical
and toxicologic data, regarding a variety of
asthma risk factors. Atopy is a major herita-
ble risk factor for asthma and involves the
familial tendency to develop immediate-type
hypersensitivity (i.e., IgE-mediated) immune
responses to speciﬁc allergens (34). Although
genetic predisposition may be important in
the development of asthma, recent increases
in the prevalence and severity of asthma
seem to have occurred too rapidly to be
mediated solely by genetic shifts (35).
Environmental factors that have been
associated with adult and childhood asthma
include allergen exposure, environmental
tobacco smoke, socioeconomic status, nutri-
tion, family size, history of infections, and
ambient levels of air pollution (2,7).
Although no consensus exists on the relative
importance of each of these factors, the
development of asthma is clearly multifactor-
ial. Some scientists have hypothesized that
fetuses and infants may take the first steps
toward sensitization to environmental aller-
gens during critical windows of susceptibility
during early life, perhaps because of an envi-
ronment that encourages dominance of the
TH2 phenotype beyond fetal life (9,34).
Because components of diesel exhaust have
been shown to affect numerous inﬂammatory
and immunologic pathways in the respiratory
tract, including promoting induction of a
TH2 phenotypic response, some researchers
hypothesize that exposures to diesel exhaust
may play a role in the development or exacer-
bation of asthma and allergic disorders (36).
Composition of Diesel Exhaust
Arising from the combustion of diesel fuel in
compression-ignition engines, diesel exhaust
consists of a complex mixture of particulate
matter, including elemental carbon and
polycyclic aromatic hydrocarbons (PAHs;
i.e., phenanthrene, ﬂuorenes, naphthalenes,
pyrenes, fluoranthrenes), as well as acid
aerosols, volatile organic compounds, various
hydrocarbons (including highly reactive
quinones), and gases, including carbon diox-
ide (CO2), carbon monoxide (CO), nitric
oxide (NO), nitrogen dioxide (NO2), and
sulfur dioxide (SO2) (37). After combustion
of diesel fuel, the exhaust components tend
to aggregate into discrete, spherical, res-
pirable particles approximately 0.1–0.5 µm
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Figure 1. Immunologic pathways in asthma.
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IL-10 (produces
more TH2 cells)in diameter (38). These particles consist of an
inert carbonaceous core with a large surface
area, ideal for adsorbing heavy metals and
organic compounds such as PAHs. The
PAHs are small compounds of three to ﬁve
benzene rings that can easily diffuse through
cell membranes and bind to receptors within
the cytoplasm. One such receptor is the aro-
matic hydrocarbon receptor complex (36). In
addition, diesel exhaust contains many sub-
stances that are listed as toxic air pollutants
by the State of California and as hazardous
air pollutants by the U.S. Environmental
Protection Agency (37,39).
Buses, trucks, and other heavy industrial
transport vehicles are major sources of ambi-
ent diesel exhaust pollution. Utilization of
diesel fuel has steadily increased in the United
States over the past several decades: the num-
ber of miles traveled by commercial trucks in
the United States has increased by 235%
between 1950 and 1985, and cargo tonnage
carried by trucks has increased by 169% (40).
DEPs are major sources of ambient
PM2.5 (41). In California, an estimated
26% of all particulate matter from fuel
combustion sources arises from the combus-
tion of diesel engines (41). In 1996, diesel
exhaust also comprised a quarter of the NO
smog precursors released nationally in the
United States (39).
Epidemiologic Studies Linking
Diesel Exhaust and Asthma
There is some epidemiologic evidence associ-
ating exposure to high levels of diesel exhaust
with asthma. Wade and Newman (42)
describe three railroad workers who traveled
in locomotive units directly behind the lead
diesel-powered locomotive engine and even-
tually developed acute or subacute onset of
respiratory symptoms. They demonstrated
symptoms consistent with asthma, including
hyperreactive airways, airﬂow limitation, and
reversibility with bronchodilators. None of
these workers had any known preexisting res-
piratory conditions. Numerous components
within diesel exhaust are respiratory irritants
(38), including some of the acid aerosols,
volatile organic compounds, and gases in the
mixture. The irritant effect alone could
potentially trigger asthmatic symptoms at
sufﬁciently high exposure levels.
Although exposure to acutely high levels
of diesel exhaust can produce respiratory
symptoms, there is also epidemiologic evi-
dence that chronic exposure to diesel exhaust
at lower environmental levels may also be
associated with increased levels of respiratory
symptoms. For instance, children living near
busy diesel trucking routes have decreased
lung function in comparison with children
living near roads with mostly automobile
traffic (10). A population-based survey of
more than 39,000 children living in Italy
found that children living on streets with
heavy truck trafﬁc were 60–90% more likely
to report acute and chronic symptoms such
as wheeze, phlegm, and diagnoses such as
bronchitis, bronchiolitis, and pneumonia
(43). A German study of over 3,700 adoles-
cent students found that those living on
streets with “constant” truck traffic were
71% more likely to report symptoms of
allergic rhinitis and more than twice as likely
to report wheezing (44).
Diesel Exhaust Gases and
Potential Adverse Respiratory
Effects
Diesel exhaust contains many well-known
air pollutants that have been associated with
asthma exacerbations (45), including SO2,
NO2, and fine particulate matter smaller
than 10 µm in size (PM10), which are all cri-
teria air pollutants (39).
Several studies have found temporal asso-
ciations between ambient particulate levels
(PM10) and emergency department admis-
sions for exacerbations of asthma (16,17,46).
Some recent studies have also shown rela-
tionships between both daily and long-term
levels of SO2 and child hospital visits for res-
piratory diseases (11,47). SO2 causes bron-
choconstriction in asthmatics during exercise.
These effects are above and beyond the
effects of exercise alone. Adult asthmatic sub-
jects exposed to ambient concentrations (0.5
ppm SO2) during just a few minutes of mod-
erate exercise experienced signiﬁcant drops in
forced expiratory volume in 1 sec (FEV1)
(48,49). There is also evidence that short-
term exposure of asthmatics to NO2 at ambi-
ent atmospheric levels may increase airway
responsiveness to SO2 (50). Therefore, it is
possible that some of the gases related to
diesel exhaust may trigger exacerbations of
asthmatic and allergic symptoms in already
asthmatic subjects (51–53).
Several epidemiologic studies have
reported associations between daily and
chronic levels of NO2 and exacerbations of
asthma (12,24,26,54). Toxicologic evidence
indicates that NO2 is directly harmful to the
respiratory system. Normal healthy subjects
exposed for 2 hr to 2 ppm NO2 demon-
strated increases in IL-8 and neutrophils
(55). An in vitro study exposed human nasal
mucosal tissues to NO2 and ozone and
reported elevated histamine levels (56).
Another study that exposed mildly asthmatic
human subjects to 260 ppb (500 µg/m3)
NO2 for 30 min found that the response to
an inhaled allergen was enhanced after the
NO2 exposure (57).
Acute exposures to diesel exhaust, even
at low concentrations, have been shown to
elicit inﬂammatory responses. There is some
evidence to suggest that the inflammatory
response from diesel exhaust may not simply
be due to SO2 and NO2 exposures. Fifteen
nonasthmatic volunteers exposed for 1-hr
periods to diesel exhaust (at PM10 concen-
trations of 300 µg/m3 and NO2 concentra-
tions of 1.6 ppm) developed elevated levels
of neutrophils, macrophages, B cells, mast
cells, T lymphocytes, histamine, endothelial
adhesion molecules, and lactate dehydroge-
nase in their airways at 6 hr postexposure
(58). Such effects do not occur in nonasth-
matics exposed to NO2 alone at comparable
concentrations, making the particles the
more likely culprit. An in vitro study found
that exposure of human bronchial epithelial
cells to unfiltered diesel exhaust released
inflammatory cytokines, whereas diesel
exhaust that was ﬁltered (and therefore con-
tained gases but no particulate matter) did
not have this effect (59). These studies sug-
gest that the particulate components of
diesel exhaust may play a more significant
role in triggering airway inﬂammation than
the gaseous components.
Molecular Mechanisms of
Action of DEPs in the
Respiratory Tract
It is not entirely clear which DEP compo-
nents produce toxicity. Some studies suggest
that the majority of the toxicity is attribut-
able to the adsorbed organic compounds
(38,60,61), whereas others conclude that the
most toxic portion of a DEP is the carbona-
ceous core (15). Regardless of which speciﬁc
components of DEPs are most toxic, it
appears that DEPs may be associated with
both early and late phases of the inﬂamma-
tory response in asthma.
Typically, the early asthmatic phase is
predominantly IgE mediated, whereas the
late phase involves complex networks of
inflammatory mediators, including
eosinophils, T cells, cytokines, chemokines,
and immunoglobulins (30).
There are numerous hypothesized inter-
actions of DEPs with the immune and respi-
ratory systems. DEPs may act directly to
alter specific immunologic pathways that
may precipitate acute exacerbations of
asthma. Direct effects of DEPs include stim-
ulation of IgE production, eosinophilic
degranulation, augmentation of cytokine
and chemokine production and release, free
radical formation, and effects on production
of NO in the airways (62). As an adjuvant
with environmental allergens, DEPs appear
to enhance the differentiation of CD4+
T lymphocytes into the TH2 phenotype and
enhance allergen-specific IgE and IgG pro-
duction. The potential pathways by which
DEPs may promote asthma are summarized
in Table 1.
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Table 1. Molecular effects of diesel exhaust particles.
Category of
Mechanism of action Clinical relevance evidence Major ﬁndings
Increase in IgE production Stimulates mast cells to release  Human studies DEPs alone increase IgE and IgE mRNA in nasal lavage ﬂuid (63)
histamine and other mediators of  DEPs and allergen increase IgE and stimulate isotype switching
acute hypersensitivity upon exposure  (45,71,86)
to an allergen Nasal challenge with DEPs results in a de novo IgE response to a 
neoantigen (108)
Animal studies No effect on IgE levels post-DEPs alone (66,68,81)
Adjuvant effect of DEPs with allergen on IgE production 
(69,72,73,82,87,114–116)
No clear adjuvant effect on IgE in mice exposed to DEPs and 
allergen (68,70,77)
In vitro studies Phenanthrene and other PAHs from diesel exhaust increase IgE 
production by B cells (45,64,67)
Enhanced IgG production Association with delayed and chronic  Human studies DEPs with allergen increases allergen-speciﬁc IgG4 and
asthmatic responses IgE levels (45,86)
No effect on IgG4 from DEPs alone (63)
Animal studies DEPs with allergen results in greater antiallergen IgG1 antibody 
levels (72,81,82,85,87,115–117)
No adjuvant effect on immunoglobulins observed (68,77)
Enhanced activity of eosinophils Mediator of chronic bronchial  Human studies No increase in eosinophils after DEP exposure alone (75)
inﬂammation, including prolonged  Animal studies DEPs alone increase eosinophil inﬁltration in mouse airways—
muscle contraction, increased bronchial  blocked by treatment with superoxide dismutase (99,104)
hyperresponsiveness, and mucosal  Exposure to DEPs and allergen enhances eosinophil recruitment 
damage (68,77,81,82,87,115)
In vitro studies DEPs enhance eosinophil adhesion to nasal epithelial cells and 
induce eosinophil degranulation (76)
Effect on T-lymphocyte  TH2-type phenotype is associated with a Human studies Induction of TH2-type cytokine expression (i.e., IL-4, IL-5, IL-6, 
differentiation and promotion of  propensity to asthmatic and allergic IL-10, IL-13) by DEPs with or without allergen (45,65,79,86)
TH2-type cytokine production responses
Cytokines mediate immunologic pathways  Animal studies Increased TH2 cytokines in the airway and the gut 
involved in acute and chronic asthmatic  (77,80–82,85,87,117)
and allergic symptoms
Increased levels of speciﬁc 
cytokines (interleukins)
IL-4 Mediates immunoglobulin class switching  Human studies DEPs alone increase IL-4 in nasal lavage ﬂuid (65,79)
of B cells from IgM to IgE
Stimulates differentiation of T cells into a  Combination of DEPs and allergen increases IL-4 levels 
TH2 phenotype (45,71,86)
Activates eosinophils Animal studies Intratracheal exposure to DEPs and allergen enhances IL-4 
production (80,87)
In vitro studies Pyrene induces expression of IL-4 protein in human T cells (78)
DEPs and antigen stimulate IL-4 production in mouse spleen cells 
(69,72)
IL-5 Growth factor for eosinophils Human studies DEPs increase IL-5 levels (65)
DEPs plus allergen increase IL-5 and other TH2 cytokines in the 
nasal lavage ﬂuid of healthy humans (45,86)
Animal studies DEPs plus allergen increase IL-5 in lung tissue of mice 
(77,81,82,85)
IL-8 An important mediator in neutrophil  Human studies DEPs increase IL-8 in the bronchial wash and epithelium (84)
recruitment to the respiratory tract in  No change in IL-8 in bronchioalveolar lavage ﬂuid of normal 
acute, severe asthma subjects with DEPs alone (58)
In vitro studies DEPs enhance IL-8 release from human nasal and bronchial 
epithelial cells (38,59,60,91–94,96)
Effects on other inﬂammatory 
mediators
GM–CSF Prolongs the survival of eosinophils,  Human studies No effect on GM–CSF levels after exposure to diesel exhaust (84)
neutrophils, and macrophages
Augmented GM–CSF production observed  Animal studies Increase in GM–CSF mRNA expression in the lungs of mice 
in cells involved in asthmatic activity intranasally exposed to DEPs (66)
Increase in GM–CSF in mice exposed to DEPs and allergen 
(77,87)
In vitro studies Endocytosis of organic compounds in DEPs by human respiratory 
epithelial cells causes secretion of GM–CSF (38,60,93,94,96,97)
RANTES  Chemokine central to the delivery of  In vitro studies DEPs increase expression of the RANTES gene in human
eosinophils to the airway bronchial epithelial cells (92,96)
TNF-α Proinﬂammatory cytokine that inﬂuences  Human studies No change in levels of TNF-α after exposure to DEPs alone (84)
eosinophil recruitment Animal studies Increased synthesis and secretion of TNF-αfrom macrophages (61)
(continued)Direct Immunologic Effects 
of DEPs
Enhanced IgE Production by Effects
on B Lymphocytes
DEPs consistently enhance the production
of IgE in the airways (63–65). IgE is pro-
duced by activated B cells in response to a
specific allergen. Once produced, IgE
attaches to mast cells and, when cross-linked
by allergen, induces mast cells to release hist-
amine and leukotrienes. The chemicals
released from mast cells cause constriction of
bronchial smooth muscle, mucus secretion,
and serum leakage into the airways and
result in acute asthma symptoms (30). The
mast cell is often considered the central cell
type in the acute asthmatic response, and
IgE is the critical immunoglobulin driving
the mast cell response.
In a study of eleven nonsmoking, non-
allergic volunteers, Diaz-Sanchez et al. (65)
showed that exposure to DEPs signiﬁcantly
increases IgE levels in nasal ﬂuids by greatly
increasing the numbers of IgE-secreting cells
and by altering the expression of IgE
mRNA isoforms. In comparison, there was
no effect on IgG, IgA, or IgM antibody pro-
duction. This suggests that DEP exposure
in vivo induces both a quantitative increase
in IgE production and a shift in the type of
IgE that is produced. Although most studies
support the ﬁnding that DEPs increase IgE
synthesis (63–65), one study in mice failed
to find an increase in IgE synthesis from
DEPs alone (66).
In vitro evidence suggests that IgE-
secreting B cells may be directly stimulated
by DEPs. For instance, PAHs from DEPs
were able to induce production of IgE in
puriﬁed human B cells treated with IL-4 and
CD-40 (67). Another study demonstrated
that phenanthrene, a major PAH in DEPs,
increased IgE in human B cells transformed
by Epstein-Barr virus (64). The IgE stimula-
tion by phenanthrene was accompanied by
an increased expression of total IgE mRNA.
In addition, several studies have found that
the DEP-mediated increase in IgE synthesis
may be ampliﬁed when DEPs act as an adju-
vant to environmental allergens (68–73).
Stimulation of Eosinophils
Diesel exhaust may also stimulate the prolif-
eration of eosinophils. Eosinophil production
is regulated by IL-3, IL-5, and GM–CSF.
The granules of mature eosinophils contain
chemokines, leukotrienes, and toxic proteins.
Degranulation of eosinophils in mucosal tis-
sues results in bronchial inflammation and
contributes to asthmatic symptoms (74). Just
as mast cells are regarded as the central cell
for the acute asthmatic response, eosinophils
are often regarded as the critical cell type in
chronic asthma.
DEPs may enhance eosinophilic inﬁltra-
tion into the respiratory tract and subsequent
degranulation. Healthy human volunteers
exposed to diesel exhaust had increased
eosinophils and other inflammatory mole-
cules on bronchial biopsies 6 hr after expo-
sure (58). However, a similar study did not
detect increased eosinophils in induced sputa
4 hr after exposure to DEPs (75). Induced
sputa are less sensitive than bronchial biopsies
at detecting subtle inﬂammatory changes in
the lower airway. Eosinophils incubated with
DEPs had enhanced adherence to human
nasal epithelial cells and enhanced levels of
degranulation (76). In animal assays, the
DEP-induced eosinophilia is enhanced in the
presence of allergens such as ovalbumin
(OVA) and is accompanied by enhanced air-
way hyperresponsiveness to acetylcholine
challenge (68,77).
Inﬂuence on Cytokine Expression
Exposure to DEPs may augment levels of
many different cytokines (soluble protein
immune mediators such as interleukins) and
chemokines (attractant proteins that induce
migration of different cell types). These
molecules are key chemical messengers in the
inflammatory processes of asthma. Various
interleukins stimulate T-cell switching
between TH1 and TH2 subtypes, stimulate
B cells, attract and prolong the survival of
eosinophils, and play other roles orchestrat-
ing the immunologic cascade that results in
an allergic or asthmatic response.
Augmentation of interleukin levels.
DEPs and associated polyaromatic hydrocar-
bons may increase levels of some inter-
leukins. For example, healthy humans
exposed nasally to 0.15 mg of DEPs sus-
pended in 200 µL of saline expressed TH2-
type cytokines (i.e., IL-4, IL-5, IL-6, IL-10)
in their nasal mucosal cells 18–24 hr after
exposure (65).
IL-4 production may be enhanced by
pyrene, a PAH found in DEPs (78). The
molecular mechanism of this effect may be
upregulation of IL-4 mRNA transcription.
IL-4 is a TH2-type cytokine that induces iso-
type switching in B cells to alter antibody
production from the IgM to IgE isotype and
is also central to the production of IgE (79).
DEPs may enhance IL-4 production more
effectively with allergen than it does alone.
Mice injected intratracheally with DEPs plus
Japanese cedar pollen manifested an IL-4
production about twice as high as that seen
in mice injected with Japanese cedar pollen
alone (80). This enhancement in IL-4 pro-
duction increased to an 8-fold level in mice
injected with OVA and DEPs compared
with mice receiving only OVA. A later study
examining cytokine production in DEP-
exposed and control mice sensitized with
OVA found that IL-4 and IL-10 production
in spleen cells was signiﬁcantly increased in
the group of DEP-exposed mice (69). In
addition, humans challenged with DEPs
plus ragweed antigen had enhanced local
IgE, IL-4, and IL-13 production accompa-
nied by isotype switching from IgM or IgD
to IgE antibody in nasal lavage cells (71). In
comparison, isotype switching did not occur
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Table 1. Continued.
Category of
Mechanism of action Clinical relevance evidence Major ﬁndings
Enhanced superoxide production  Reactive oxygen molecules that directly  Animal studies Increased superoxide production via P450 reductase after 
and inhibition of antioxidant effects injure airway epithelium and promote  intratracheal treatment with DEPs (101)
apoptosis in macrophages, thereby 
generating more free radicals
Superoxide levels increase in response to  In vitro studies Inhibition of superoxide dismutase activity and catalase activity
the adsorbed organic molecules on DEP by DEPs (102,103)
Organic components in DEPs induce apoptosis in macrophages (100)
Effects on NO Important mediator of airway inﬂammation Animal studies Increased inducible and constitutive NOS in murine airways after 
DEP exposure (101)
Aggravation of airway inﬂammation in mice by DEP-mediated 
increase in the inducible form of NOS (105)
In vitro studies Inhibition of NO release from bronchial and aortic ring cells by 
DEPs (106)
DEPs and allergen binding Promotes synergistic response due to  In vitro studies Pollen and other allergens bind to DEPs (70,110,111)
co-delivery to the mucosain those challenged with ragweed antigen or
DEPs alone.
Levels of IL-5 are also increased after
DEP exposure. IL-5 is an important factor
for the proliferation and activation of
eosinophils after exposure to certain aller-
gens such as OVA and pollen (81,82). A
recent study found that mRNA expression
for IL-5 was significantly lower in patients
who had no nasal symptoms when com-
pared with those who required medicines to
control allergic symptoms during pollen sea-
son (83). Two human studies found that
exposure to DEPs resulted in increased lev-
els of IL-5 (65,84). However, other human,
animal, and in vitro studies found that diesel
exhaust alone did not result in any IL-5
response (38,66,81,82,85).
Despite the conﬂicting results about the
effect of DEPs alone on IL-5, DEPs consis-
tently increase IL-5 levels in the presence of
environmental allergens. For instance,
healthy human subjects exposed to DEPs
with ragweed antigen had significantly
increased levels of IL-5 and other TH2
cytokines in nasal lavage fluid (86). Mice
exposed to diesel exhaust combined with
OVA sensitization had increased expression
of IL-5 in lung tissue and developed airway
inflammation and hyperresponsiveness
(77,81,82,87). Instillation of OVA and
DEPs together produced a 3- to 4-fold
increase in IL-5 in mouse lung tissue com-
pared with the levels in mice exposed to
OVA or DEPs alone (77). DEPs may
enhance the symptoms of allergic rhinitis by
a synergistic effect with pollen to increase
IL-5 secretion (86).
DEPs also increase the presence of IL-8,
a member of the CXC chemokine family.
Produced primarily by macrophages, IL-8 is
one of the most important mediators in the
recruitment of neutrophils to the respiratory
tract (88). Neutrophils appear to be impor-
tant inflammatory leukocytes in airway
secretions of patients with acute severe
asthma (89). IL-8 appears to play an impor-
tant role in augmenting the numbers of acti-
vated eosinophils in asthmatic patients (90).
Increased IL-8 levels are found in
bronchial washings and bronchial tissues of
healthy humans exposed to diesel exhaust
levels similar to those in the ambient air of
many cities (84). In vitro exposure to DEPs
has also been found to enhance the release of
IL-8 from various types of airway cells,
including human bronchial epithelial cells
(38,60,91–93), human mucosal microvascu-
lar endothelial cells (94), and human nasal
epithelial cells (38,94).
Effect on other inﬂammatory mediators.
DEPs may enable the release of several addi-
tional molecules involved in airway inflam-
mation. In animal and in vitro models,
DEPs increase GM–CSF. In both animals
and humans, GM–CSF is thought to sustain
the asthmatic response by prolonging the
survival of eosinophils and neutrophils (95).
Mice intranasally exposed to DEPs devel-
oped bronchial constriction associated with
increased levels of GM–CSF in bronchial
epithelial cells; blocking the GM–CSF
response abolished the DEP-evoked airway
hyperresponsiveness (66). DEP-induced
increases in GM–CSF were also shown
in vitro in exposed human bronchial epithe-
lial cells (60,93,96), human mucous mem-
brane epithelial cells, and human nasal
epithelial cells (38,94). However, no effect
on GM–CSF levels in bronchial cells was
found in one study of human volunteers
exposed to diesel exhaust (84).
Proposed mechanisms by which DEPs
may increase GM–CSF include increased
expression of the histamine H1 receptor (94)
and free radical production, which may
independently elevate GM–CSF levels (97).
A recent study demonstrated that free radical
scavengers inhibit the DEP-mediated
GM–CSF release in airway epithelial cells
(97), providing some support for the latter
hypothesis. Free radical production is part of
the inﬂammatory pathway discussed in more
detail below.
Expression of Chemokines
DEPs have been shown to increase the expres-
sion of RANTES (regulated upon activation,
normal T-cell expressed and secreted), a
chemokine that is central to the delivery of
eosinophils to the airway (30). RANTES also
plays a role in attracting leukocytes during the
inﬂammatory response (98). Upon exposure
to DEPs, expression of the gene for RANTES
was increased in the bronchial epithelial cells
of asthmatic (96) and nonasthmatic individu-
als (92). Although DEPs enhance both IL-8
and RANTES, an inhibitor of p38 mitogen-
activated protein (MAP) kinase apparently
prevents these effects. p38 MAP kinase is
thought to be important in the signal trans-
duction pathway leading to upregulation of
nuclear factors (e.g., activator protein 1 [AP-
1] and nuclear factor kappa B [NFκB]) that
activate the transcription of genes for IL-8
and RANTES. Thus, DEPs may enhance IL-
8 and RANTES through activation of the
p38 MAP kinase pathway in human
bronchial epithelial cells, which leads to
upregulation of nuclear transcription factors
AP-1 and NFκB (92).
Inﬂammatory Effects of DEPs
Although DEPs may have numerous effects
on the immunologic cascade involved in
allergy and asthma, there is also some evi-
dence that these particles may have a more
direct irritant or cytotoxic effect in the
respiratory tract. Although there is overlap
between the two pathways, this inflamma-
tory mode of action is somewhat distinct
from the more immunologic effects
described above. The inﬂammatory pathway
in asthma is shown in Figure 2.
Enhanced Superoxide Production
DEPs may induce the production of oxidants
such as superoxide (O2
–) and hydroxyl radi-
cal (OH–), reactive compounds that can
cause direct damage to the pulmonary
epithelium (99). Superoxides appear to be
part of a cellular response against the
adsorbed organic molecules on DEPs and
may promote apoptosis in macrophages
(100), thereby causing release of more
inflammatory and cytotoxic molecules.
Intratracheal DEP exposure in mice enhances
the activity of P450 reductase, an enzyme
that increases production of superoxide. This
provides a possible mechanism by which
DEPs may stimulate superoxide production
(101). While increasing superoxide produc-
tion, DEPs may also reduce the superoxide
scavenging activities of superoxide dismutase
(SOD) and glutathione in vitro. For example,
when the antioxidant catalase was exposed to
the oxidant stress of hydrogen peroxide
(H2O2) in the presence of DEPs and chlo-
rine, the activity of the catalase was inhibited
dose dependently (102).
This type of inhibitory activity by DEPs
can reduce the capacity of the body to
counteract oxidants (e.g., H2O2), thereby
providing another mechanism for cellular
injury. Lim et al. (101) provide evidence
for this by demonstrating that the activity
of CuZn–superoxide dismutase (SOD) and
Mn–SOD was decreased after intratracheal
exposure to DEPs in mice. DEPs may also
inhibit the activity of antioxidants through
a deactivating reaction between SOD and
quinones, which are present on the surface
of DEPs (103). Therefore, DEPs appear to
increase the superoxide load yet decrease
the body’s innate superoxide scavenging
activity, which leads to potentially higher
levels of cytotoxicity.
Increases in superoxides may be a key
factor in asthmatic and allergic responses.
For instance, pretreatment with poly-
ethyleneglycol-conjugated SOD suppressed
DEP-related airway alterations in mice,
including inﬁltration of inﬂammatory cells,
mucus hypersecretion, and airway constric-
tion (99,104). This illustrates that direct cel-
lular toxicity by superoxides may play a role
in asthma. Superoxides may also activate
intracellular signaling pathways, including
those involving NFκB and AP-1, that upreg-
ulate chemokine and cytokine expression.
This may help mediate and sustain inflam-
matory responses in asthma.
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DEPs may be capable of influencing NO
production. NO is elevated in asthmatic
patients and has been proposed as a biologic
marker for airway inﬂammation (105,106).
NO is synthesized from the amino acid argi-
nine by the enzyme nitric oxide synthase
(NOS). NO is normally released constitu-
tively by one isoform of NOS, but NO may
also be produced from augmented expres-
sion of inducible forms of NOS by various
stimuli. However, the precise role of NO in
asthma is not clear. Interestingly, it appears
that NO produced by constitutive NOS
may have anti-inﬂammatory effects, whereas
NO produced from inducible forms of NOS
may have proinﬂammatory effects (105).
DEPs may affect both the constitutive
and inducible NOS pathways. Intratracheal
exposure of mice to DEPs increased produc-
tion of both the constitutive and inducible
NOS isoforms (101). However, another
study found that DEP-induced airway
inﬂammation was aggravated by NO gener-
ated from the inducible form of NOS (105).
This study suggested that DEPs may aggra-
vate airway inflammation by inhibition of
NO production by the constitutive form of
NOS.
Although DEPs may alter the NO path-
way, the implications for asthma are not
clear. One theory is that NO may react with
superoxide to form a compound called
peroxynitrite that may play a key role in the
development of airway inflammation and
hyperresponsiveness (101).
Adjuvant Immunologic Effects
of DEPs
Although DEP exposure alone can elicit
adverse biologic effects in the airway, the
effect of DEPs has been repeatedly shown to
be even greater in conjunction with allergens
(82,87). For example, mice exposed
intranasally to DEPs and OVA have far
greater levels of anti-OVA IgE than mice
exposed solely to DEPs or OVA alone (73).
Guinea pigs exposed for 4 weeks to diesel
exhaust and challenged with histamine expe-
rienced nasal mucosal hyperresponsiveness,
sneezing, and nasal secretion, while those
exposed to either diesel exhaust or histamine
alone had far weaker responses (107).
An innovative study of 10 nonsmoking
atopic human subjects tested the potential
for DEPs to create a brand new immune
response to an allergen. The investigators
exposed the atopic subjects on three occa-
sions to the neoantigen keyhole limpet
hemocyanin (KLH), a compound to which
humans are not normally sensitized.
Twenty-four hours prior to each exposure to
the new antigen, the subjects were exposed
nasally to a concentration of DEPs roughly
equivalent to 1–3 days of breathing
Los Angeles air. Subjects exposed to KLH
alone did not develop IgE antibodies to this
compound, whereas subjects exposed to
DEPs followed by KLH developed KLH-
specific IgE and mounted a TH2-type
cytokine response with increased levels of IL-
4. This important study indicates that DEPs
may promote new allergic sensitization to
antigens in addition to aggravating existing
allergic diseases (108).
Theories as to how DEPs may have adju-
vant effects include stimulation of a TH2-
type immune response, by acting as delivery
agents for coallergens, and by increasing
allergen-speciﬁc IgE and IgG production.
DEPs and Induction of a TH2
Phenotypic Response
Exposure to diesel exhaust may induce
T cells to differentiate into a TH2 pheno-
type (34). Rather than a direct effect of
DEPs alone, this shift toward a TH2 phe-
notype seems to occur as an adjuvant effect
of DEPs with allergens. In the presence of
allergen, DEPs stimulate the release of
TH2-specific cytokines (i.e., IL-4, IL-5,
IL-6, IL-10, and IL-13). These cytokines
appear to play a major role in the molecular
pathophysiology underlying the clinical
manifestations of asthma and allergies.
Increased levels of TH2-type cytokines have
stimulatory effects on B cells, enhancing
IgE production, as discussed above. In a
study of 13 nonsmoking volunteers, Diaz-
Sanchez et al. (86) found that exposure to
DEPs plus ragweed results in increased
expression of all of the TH2-type cytokines
in nasal lavage fluid and decreased expres-
sion of TH1-type cytokines. A study of 27
nonsmoking volunteers with known aller-
gies found that intranasal coadministration
of DEPs and an allergen to which the sub-
jects are sensitized stimulates a dramatic
increase over 18 hr of TH2-type cytokines
such as IL-4 and IL-6. The initial produc-
tion of these cytokines appears to derive
from mast cells in the mucosa (79).
The precise mechanism of how DEPs
stimulate the TH2 pathway has not been
determined. However, the time during
development when an organism is exposed
to DEPs may be vital in priming the
immune system for development and main-
tenance of the TH2 pattern. Exposure to
DEPs and environmental allergens during
early life may predispose individuals to
asthma and allergic disorders later in life by
promoting the expression of TH2 pheno-
typic responses (34,109).
Physical Interactions between DEPs
and Allergens
DEPs may enhance the immune response to
allergens by physically binding with them.
By this mechanism, DEPs may be trans-
ported with allergens such as pollen grain
fragments into human airways, where both
agents may be deposited on the mucosa at
the same location. This proximity may facili-
tate synergistic immunologic responses and
respiratory symptoms. DEPs bind strongly
with certain allergens. For instance, a study
that incubated DEPs with purified natural
grass pollen allergen, Lol p 1, for 30 min
found that this compound was bound to
DEPs with sufficient strength that it could
not be removed by washing methods (110).
Another study used immunogold labeling to
demonstrate the presence of the allergens
Can f 1 (dog) and Bet v 1 (birch pollen) on
the surface of suspended particulate matter,
similar to DEP, which was collected from
the indoor environment. In addition, the
allergens Fel d 1 (cat) and Der p 1 (house
dust mite) both attached to DEP when incu-
bated with DEP in vitro (111). 
However, actual binding of DEP to
allergen does not appear to be necessary to
the immune response. For instance, pollen
grains from timothy grass do not adhere sig-
niﬁcantly to DEP in vitro, but the combina-
tion does induce synergistic inflammatory
changes (i.e., influx of macrophages,
eosinophilic granulocytes, and granuloma
formation) in the lungs of rats (112).
Another study demonstrated that the capac-
ity of a particle to adsorb antigens was not
related to its ability to enhance allergic
responses (113). Thus, the binding or
adsorption of DEP to antigen may be less
important than the physical proximity of the
two agents on the mucosal surface.
Enhancement of IgE and IgG
Production 
Exposure to DEP and many environmental
allergens has been shown to augment both
IgE and IgG production. Both IgE and IgG1
antibodies are the result of TH2 cytokine
environments. Research in mice has demon-
strated that DEP produces allergen-specific
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Figure 2. Diesel exhaust particles and inflamma-
tory pathways in asthma.
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(85). Production of IgG1 antibodies is
dependent on TH2 lymphocytes in mice,
and has been linked in humans to delayed
asthmatic reactions. Human nasal instilla-
tion studies involving exposures to 0.30 mg
DEP (equivalent to total exposure on 1–3
average days in Los Angeles) along with a
ragweed antigen challenge showed that rag-
weed-speciﬁc IgE levels peaked far higher in
the presence of DEP, with a maximum level
4 days postexposure. The levels of ragweed-
specific IgG4 (an isoform of IgG that is
linked to IgE expression) also increased in
these studies, although other forms of IgG
were not affected (45,86). 
Adjuvant IgE antibody responses were
observed in mice exposed by intraperitoneal
injection to OVA and DEPs (114).
However, another study measured IgE and
IgG responses to intratracheal instillation of
diesel exhaust and OVA sensitization in
strains of mice that were either high IgG
responders or high IgE responders. In con-
trast to the previous study, IgE production
did not change in either strain, but the com-
bined exposure dramatically increased IgG1
production and IL-2 and IL-5 levels in the
high IgG responders (85). Similar studies
(81,82,87) found that inhaled exposure to
diesel exhaust with OVA sensitization for
5–6 weeks increased both IgG1 and IgE lev-
els. Studies in mice using other allergens such
as house dust mite antigen and Japanese
cedar pollen were consistent with the litera-
ture using OVA. Mice immunized with
either of these antigens mounted a much
greater IgG1 response with exposure to DEPs
than mice exposed to the same level of aller-
gen without DEPs. A similar response was
found for IgE synthesis, indicating that both
antibodies play a role in the adjuvant effects
of DEPs on the immune response (72,113).
Guinea pigs exposed to DEPs for
5 weeks with OVA sensitization once per
week developed 7-fold greater anti-OVA
IgG antibody than guinea pigs exposed only
to ﬁltered air, indicating that the response is
not specific to mice. The exposed guinea
pigs also experienced slight concentration-
dependent increases in IgE antibody (115).
Similar results have been seen in rats, where
intranasal or intratrachial co-exposure to
DEPs and pollen grains resulted in a much
greater serum level of speciﬁc IgE and IgG1
antibodies than exposure to either alone.
Electron microscopy revealed pollen grains
in the alveoli surrounded by DEP-loaded
macrophages (116). One interesting study
examined the effects of oral ingestion of
DEPs in mice because it is known that air-
borne particulate reaches not only the lung
but also the mucosa of the gastrointestinal
tract. DEPs in the gut mucosa also appear to
act as an adjuvant, enhancing both TH1-
and TH2-type responses to allergen and
enhancing production of allergen-specific
IgG1 (117).
Conclusions and Considera-
tions for Further Research
Rising rates of asthma and allergies create a
public health imperative to identify any mod-
iﬁable environmental factors that may cause
or contribute to these diseases. Abundant evi-
dence suggests that components of diesel
exhaust can cause biologic responses that are
related to asthma. Although evidence from
research cited in this article indicates that
exposures to diesel exhaust and DEPs are
associated with the inflammatory and
immune responses involved in asthma, some
questions remain regarding the underlying
molecular mechanisms.
DEPs alone may augment levels of IgE,
trigger eosinophil degranulation, and stimu-
late release of numerous cytokines and
chemokines. DEPs also may play a role in
unleashing the cytotoxic effects of free radi-
cals in the airways. All of these cellular
mechanisms would be expected to produce
airway inflammation, bronchial smooth
muscle contraction, serum leakage, and
mucus production, thereby resulting in the
clinical symptoms of asthma. Interestingly,
DEPs appear to have a far greater impact as
an adjuvant with allergens than it has alone.
The immune events leading to the asth-
matic response are intertwined, and DEPs
likely act at numerous points on the path-
way. Stimulation of the TH2-type pathway
and increase in IgE production are two of
the most important and likely mechanisms
by which DEPs may generate and sustain an
asthmatic response. The timing of exposure
to air pollutants such as DEPs during early
life may also be critical in fostering the
persistence of the TH2 phenotype.
DEPs also have other biologic effects,
such as increasing superoxide and NO levels.
However, the evidence for these effects is
currently found only in a few animal or
in vitro studies, and key questions remain.
Although exposure to diesel exhaust appears
capable of inducing inﬂammatory changes in
the respiratory tract, this area is poorly
understood. Most important, the epidemio-
logic evidence linking diesel exhaust and
asthma is distressingly sparse because of a
paucity of studies that have collected
relevant exposure data.
More research is needed to investigate
the mechanism and the clinical relevance of
the observed adjuvant effect of co-exposure
to DEPs and allergens. One study demon-
strated that this adjuvant effect results in
increased respiratory resistance in mouse air-
ways after acetylcholine challenge (118).
This line of research will help to link the
observed immunologic alterations with clin-
ical relevance. The question of windows of
vulnerability in early life and the induction
of an allergic phenotype also requires fur-
ther investigation. Research is needed to
demonstrate more clearly the effect of DEPs
on reactive oxygen species, superoxide, and
NO production. Epidemiologic research on
allergic and/or asthmatic human popula-
tions would be particularly valuable.
Observational studies of children, including
quantitative assessment of DEP exposure
and airway function, would remove some of
the uncertainties associated with the
epidemiologic research to date.
Despite the need for further research, it
is biologically plausible that diesel exhaust
and associated particles are associated with
asthma and other allergies in humans. In
light of these ﬁndings, public health efforts
to reduce exposures to diesel exhaust are
warranted. In particular, reducing the expo-
sure of infants and children should be a pri-
ority as part of a coordinated effort to
improve the prevention and management of
childhood asthma.
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